doctor if any of these
common side effects
breast tenderness
enlargement
changes in sex drive
hair loss
headache
nausea
stomach cramps
bloating
upset
severe allergic reactions
rash
hives
itching
difficulty breathing
tightness in the chest
swelling of the mouth
face
lips
tongue
unusual hoarseness
abnormal vaginal bleeding
spotting
breakthrough bleeding
prolonged bleeding
breast lumps
pain
calf
leg pain
redness
swelling
tenderness
warmth
changes in vision
double vision
loss of vision
chest pain
coughing
blood
dizziness
fainting
mood changes
depression
migraine
worsening seizures
nipple discharge
pain
swelling
tenderness in the stomach
persistent headache
sudden shortness of breath
swelling of the hands
ankles
feet
symptoms of a heart attack
chest
jaw
arm pain
numbness of an arm
leg
severe headache
vomiting
vision changes
symptoms of a stroke
confusion
one-sided weakness
speech
vision changes
unusual vaginal discharge
itching
odor
yellowing of the skin
eyes
gastrointestinal effects
nausea
vomiting
studies
fold increase in gallbladder disease in postmenopausal women
taking estrogen therapy
cases of oral pigmentation
ischemic colitis
number of studies
risk of endometrial carcinoma
administration of progestins in combination with estrogen therapy
increased risk of breast cancer
estrogens
several studies
long-term estrogen therapy
increased risk of breast cancer
meta analysis of studies
epidemiological data
modest risk increase
long-term hormone replacement therapy
hrt
study of swedish women
increase in the relative risk of breast cancer
risk
increasing duration of estrogen therapy
study
women with more
years of estrogen use
greater relative risk of breast cancer than controls
study
examined use of a variety of estrogen preparations of which estradiol
addition
women
progestins
decreased risk of breast cancer
higher risk
toronto breast cancer study
women
unopposed conjugated estrogens for less than years
increased risk of breast cancer
study
increase in the risk of breast cancer for women
conjugated estrogens for more than years
case-control surveillance study
evidence that the use of unopposed
unopposed conjugated estrogens
risk of breast cancer
long duration of use
long latent intervals
possibility of a modest increase
doubling
nurses
health study
increased risk of breast cancer in women
taking estrogen replacement therapy
risk
concurrent use of progestins
study
greater risk
advanced age
prolonged duration of hormonal therapy
study of middle-aged women in the puget sound area
whole
use of estrogen with progestin hrt
hormone replacement therapy
increased risk of breast cancer in middle-aged women
prospective cohort study
years
women by gapstur
histology of the breast cancer in women
hrt
association
duration
hrt use
incidence of ductal carcinoma
invasive ductal/lobular carcinoma
duration
hrt use
risk of invasive carcinoma with a favorable prognosis
relative risk
rr
confidence interval
ci
hrt
yrs
rr
ci
hrt
> yrs
p
relative risk of invasive carcinoma with a favorable prognosis for current users
age
other risk factors
ci
yrs
ci
> yrs
risk of invasive ductal
lobular carcinoma for current users
yrs
rr
ci
use of unopposed estrogen therapy
increased risk of endometrial cancer in patients with an intact uterus
increased risk of breast cancer
studies
unopposed estrogen therapy
risk of coronary heart disease
combination therapy with a progestin
coronary risk
extent of risk reduction with combination therapy
data
combination therapy
overall rate of coronary heart disease in postmenopausal women with established coronary disease
reported effects of estrogens on cardiovascular activity
alterations in lipid profiles in treated women
reducing
reducing cardiovascular risks
data
estrogen use
blood pressure
patients
receiving high doses
blood pressure
change
addition
noncontraceptive use of estrogens in young women
smokers
risk of nonfatal myocardial infarction
other studies
increased risk of myocardial infarction
metabolic effects
favorable alterations in plasma lipid profiles
hdl
cholesterol
ldl levels
estrogen therapy
increased serum triglyceride levels
pancreatitis in patients with familial lipoprotein
metabolic defects
metabolic adverse effects
hypercalcemia
patients with breast cancer
bone metastases
administered estrogens
endocrine side effects with estrogen use
increased levels of thyroxin-binding globulin
leading
increase in total thyroid serum levels
decrease in resin uptake of t
free thyroid hormone levels
other endocrine effects
decreased fasting plasma glucose
close observation of patients
fluid retention
underlying asthma
epilepsy
migraine
heart disease
renal dysfunction
estrogens
degree of fluid retention
mastodynia
alterations in libido
reports of hepatic tumors
women
taking long-term oral contraceptives
tumors
women
taking isolated estrogen therapy
rare cases of focal nodular hyperplasia
liver cell adenomas
hepatic hemangiomas
well-differentiated hepatocellular carcinomas
association with estrogen therapy
aggravation of porphyria
hypercoagulability
women
taking estrogens
clinical significance of such hypercoagulability in postmenopausal women
taking estrogens
hypersensitivity reactions
anaphylaxis
association with estrogens
dyes
conjugated estrogen formulations
estrogen therapy
two-fold increase in risk
fibrocystic breast disease
psychiatric side effects
estrogen therapy
cases of rapid mood cycling in patients with severe depression
nervous system
side effects
migraine
dizziness
mental depression
estrogens
abnormal uterine bleeding
bleeding
endometrial carcinoma
addition
estrogens
size
preexisting
preexisting uterine leiomyomata
several cases of pseudoincontinence
excessive vaginal discharge
patients as urinary incontinence
post-operative estrogens
ocular side effects of estrogen therapy
alterations in corneal curvature
contact lens discomfort
dermatologic effects
chloasma
melasma
following discontinuation of estrogen therapy
scalp hair loss
hirsutism
erythema nodosum
hemorrhagic eruptions
side effects of ortho-est
fda
healthcare professional for medical advice